Literature DB >> 28012563

Should methotrexate remain the first-line drug for psoriasis?

Dafna D Gladman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28012563     DOI： 10.1016/S0140-6736(16)32574-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.

Authors:  C Liu; H Liu; C Lu; J Deng; Y Yan; H Chen; Y Wang; C-L Liang; J Wei; L Han; Z Dai
Journal:  Clin Exp Immunol       Date:  2019-08-26       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.